Back to Search
Start Over
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement.
- Source :
-
Dermatologic therapy [Dermatol Ther] 2022 Nov; Vol. 35 (11), pp. e15818. Date of Electronic Publication: 2022 Sep 22. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 1529-8019
- Volume :
- 35
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Dermatologic therapy
- Publication Type :
- Editorial & Opinion
- Accession number :
- 36097346
- Full Text :
- https://doi.org/10.1111/dth.15818